Safety and Pharmacokinetics Study of Linzagolix in Female Subjects With Normal and Impaired Hepatic Function

Completed · Phase 1

Conditions studied: Hepatic Impairment, Healthy Participants

In brief

The primary objective of this study is to assess the pharmacokinetics (PK) of linzagolix in subjects with varying degrees of impaired hepatic function compared to match control subjects with normal hepatic function

Key facts

Study ID
NCT03962049
Run by
ObsEva SA
People needed
24
Starts
2019-05-15
Expected to finish
2019-11-01
Last updated by the study team
2020-01-13

Who can join

Age: 18 and older, up to 75. Sex: female. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.